188 related articles for article (PubMed ID: 27241822)
1. Describing nutrition in spinal muscular atrophy: A systematic review.
Moore GE; Lindenmayer AW; McConchie GA; Ryan MM; Davidson ZE
Neuromuscul Disord; 2016 Jul; 26(7):395-404. PubMed ID: 27241822
[TBL] [Abstract][Full Text] [Related]
2. Nutritional Status and Nutrient Intake Challenges in Children With Spinal Muscular Atrophy.
Mehta NM; Newman H; Tarrant S; Graham RJ
Pediatr Neurol; 2016 Apr; 57():80-3. PubMed ID: 26803333
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive nutritional and metabolic assessment in patients with spinal muscular atrophy: Opportunity for an individualized approach.
Martinez EE; Quinn N; Arouchon K; Anzaldi R; Tarrant S; Ma NS; Griffin J; Darras BT; Graham RJ; Mehta NM
Neuromuscul Disord; 2018 Jun; 28(6):512-519. PubMed ID: 29699728
[TBL] [Abstract][Full Text] [Related]
4. Systematic Literature Review to Assess the Cost and Resource Use Associated with Spinal Muscular Atrophy Management.
Paracha N; Hudson P; Mitchell S; Sutherland CS
Pharmacoeconomics; 2022 Apr; 40(Suppl 1):11-38. PubMed ID: 34761360
[TBL] [Abstract][Full Text] [Related]
5. Anthropometric measurement standardization for a multicenter nutrition survey in children with spinal muscular atrophy.
Bertoli S; Foppiani A; De Amicis R; Leone A; Mastella C; Bassano M; Giaquinto E; Baranello G; Battezzati A
Eur J Clin Nutr; 2019 Dec; 73(12):1646-1648. PubMed ID: 30647441
[TBL] [Abstract][Full Text] [Related]
6. Systematic Literature Review to Identify Utility Values in Patients with Spinal Muscular Atrophy (SMA) and Their Caregivers.
Sutherland CS; Hudson P; Mitchell S; Paracha N
Pharmacoeconomics; 2022 Apr; 40(Suppl 1):39-67. PubMed ID: 34907515
[TBL] [Abstract][Full Text] [Related]
7. Measuring quality of life in children with spinal muscular atrophy: a systematic literature review.
Vaidya S; Boes S
Qual Life Res; 2018 Dec; 27(12):3087-3094. PubMed ID: 30043243
[TBL] [Abstract][Full Text] [Related]
8. A Systematic Literature Review of the Natural History of Respiratory, Swallowing, Feeding, and Speech Functions in Spinal Muscular Atrophy (SMA).
Martí Y; Aponte Ribero V; Batson S; Mitchell S; Gorni K; Gusset N; Oskoui M; Servais L; Deconinck N; McGrattan KE; Mercuri E; Sutherland CS
J Neuromuscul Dis; 2024 Jun; ():. PubMed ID: 38943396
[TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy.
Dachs E; Piedrafita L; Hereu M; Esquerda JE; Calderó J
Neuroscience; 2013 Oct; 250():417-33. PubMed ID: 23876328
[TBL] [Abstract][Full Text] [Related]
10. Responsiveness of the motor function measure in patients with spinal muscular atrophy.
Vuillerot C; Payan C; Iwaz J; Ecochard R; Bérard C;
Arch Phys Med Rehabil; 2013 Aug; 94(8):1555-61. PubMed ID: 23380348
[TBL] [Abstract][Full Text] [Related]
11. Profiles of neuromuscular diseases. Spinal muscular atrophy.
Carter GT; Abresch RT; Fowler WM; Johnson ER; Kilmer DD; McDonald CM
Am J Phys Med Rehabil; 1995; 74(5 Suppl):S150-9. PubMed ID: 7576422
[TBL] [Abstract][Full Text] [Related]
12. Dysphagia Phenotypes in Spinal Muscular Atrophy: The Past, Present, and Promise for the Future.
McGrattan KE; Graham RJ; DiDonato CJ; Darras BT
Am J Speech Lang Pathol; 2021 May; 30(3):1008-1022. PubMed ID: 33822657
[TBL] [Abstract][Full Text] [Related]
13. [Clinical, electrophysiological and molecular study of 26 chilean patients with spinal muscular atrophy].
Castiglioni C; Levicán J; Rodillo E; Garmendia MA; Díaz A; Pizarro L; Contreras L
Rev Med Chil; 2011 Feb; 139(2):197-204. PubMed ID: 21773657
[TBL] [Abstract][Full Text] [Related]
14. Cardiac pathology in spinal muscular atrophy: a systematic review.
Wijngaarde CA; Blank AC; Stam M; Wadman RI; van den Berg LH; van der Pol WL
Orphanet J Rare Dis; 2017 Apr; 12(1):67. PubMed ID: 28399889
[TBL] [Abstract][Full Text] [Related]
15. Long-term exercise-specific neuroprotection in spinal muscular atrophy-like mice.
Chali F; Desseille C; Houdebine L; Benoit E; Rouquet T; Bariohay B; Lopes P; Branchu J; Della Gaspera B; Pariset C; Chanoine C; Charbonnier F; Biondi O
J Physiol; 2016 Apr; 594(7):1931-52. PubMed ID: 26915343
[TBL] [Abstract][Full Text] [Related]
16. Spinal muscular atrophy: survival pattern and functional status.
Chung BH; Wong VC; Ip P
Pediatrics; 2004 Nov; 114(5):e548-53. PubMed ID: 15492357
[TBL] [Abstract][Full Text] [Related]
17. Delay in Diagnosis of Spinal Muscular Atrophy: A Systematic Literature Review.
Lin CW; Kalb SJ; Yeh WS
Pediatr Neurol; 2015 Oct; 53(4):293-300. PubMed ID: 26260993
[TBL] [Abstract][Full Text] [Related]
18. Loganin possesses neuroprotective properties, restores SMN protein and activates protein synthesis positive regulator Akt/mTOR in experimental models of spinal muscular atrophy.
Tseng YT; Chen CS; Jong YJ; Chang FR; Lo YC
Pharmacol Res; 2016 Sep; 111():58-75. PubMed ID: 27241020
[TBL] [Abstract][Full Text] [Related]
19. Management of children with spinal muscular atrophy type 1 in Australia.
Tassie B; Isaacs D; Kilham H; Kerridge I
J Paediatr Child Health; 2013 Oct; 49(10):815-9. PubMed ID: 23834358
[TBL] [Abstract][Full Text] [Related]
20. Prominent fatigue in spinal muscular atrophy and spinal and bulbar muscular atrophy: evidence of activity-dependent conduction block.
Noto Y; Misawa S; Mori M; Kawaguchi N; Kanai K; Shibuya K; Isose S; Nasu S; Sekiguchi Y; Beppu M; Ohmori S; Nakagawa M; Kuwabara S
Clin Neurophysiol; 2013 Sep; 124(9):1893-8. PubMed ID: 23643309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
